<DOC>
	<DOCNO>NCT00004981</DOCNO>
	<brief_summary>The purpose study look safety effectiveness pill call Trizivir combination three anti-HIV drug ( zidovudine , lamivudine , abacavir ) . Zidovudine lamivudine often give combine one pill ( Combivir ) . In study , Trizivir compare Combivir plus abacavir .</brief_summary>
	<brief_title>Safety Effectiveness Three Anti-HIV Drugs Combined One Pill ( Trizivir )</brief_title>
	<detailed_description>Patients randomize receive either triple combination tablet ( Trizivir ) receive Combivir plus abacavir separate tablet . Patients take study medication 24 week .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Abacavir</mesh_term>
	<mesh_term>Dideoxynucleosides</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Lamivudine , zidovudine drug combination</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are least 18 year old . Are HIVpositive . Are currently receive one follow antiHIV drug combination : Combivir plus abacavir , Combivir plus abacavir plus protease inhibitor , Combivir plus abacavir plus nonnucleoside reverse transcriptase inhibitor ( NNRTI ) . Patients must take drug combination least past 16 week . This also must first antiHIV drug combination patient receive . Have viral load ( level HIV blood ) less equal 400 copies/ml . Have CD4+ cell count great 200 cells/mm3 . Agree use effective method birth control . Exclusion Criteria Patients eligible study : Have diagnose AIDS . Have gastrointestinal disorder make difficult patient absorb food take medication mouth . Have hepatitis . Have serious medical condition , diabetes , congestive heart failure , heart disease . Are allergic study drug . Abuse alcohol drug . Will available entire 24week study period . Are pregnant breastfeeding . Have take need take certain medication , include radiation therapy , chemotherapy , drug affect immune system ( interleukin ) , HIV vaccine , foscarnet , hydroxyurea . Are enrol another experimental drug study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2001</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Drug Administration Schedule</keyword>
	<keyword>Lamivudine</keyword>
	<keyword>RNA , Viral</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
	<keyword>Combivir</keyword>
	<keyword>abacavir</keyword>
</DOC>